These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 400581

  • 1. Endotoxin-induced intravascular coagulation (DIC) and its therapy.
    Prager RL, Dunn EL, Kirsh MM, Penner JA.
    Adv Shock Res; 1979; 2():277-87. PubMed ID: 400581
    [Abstract] [Full Text] [Related]

  • 2. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
    Gómez C, Páramo JA, Rocha E.
    Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
    [Abstract] [Full Text] [Related]

  • 3. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
    Bregengård C, Nordfang O, Wildgoose P, Svendsen O, Hedner U, Diness V.
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
    [Abstract] [Full Text] [Related]

  • 4. Treatment of disseminated intravascular coagulation (DIC) with all-trans retinoic acid in an endotoxin-induced rat model.
    Aoshima K, Asakura H, Yamazaki M, Saito M, Kumabashiri I, Morishita E, Ontachi Y, Mizutani T, Ichino T, Matsuda T.
    Semin Thromb Hemost; 1998 Oct; 24(3):227-31. PubMed ID: 9701452
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of antithrombin III in endotoxin-induced disseminated intravascular coagulation.
    Hauptman JG, Hassouna HI, Bell TG, Penner JA, Emerson TE.
    Circ Shock; 1988 Jun; 25(2):111-22. PubMed ID: 3390893
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic modalities to ameliorate endotoxin induced DIC in the rats.
    Bahrami S, Paul E, Redl H, Schlag G.
    Prog Clin Biol Res; 1989 Jun; 308():977-82. PubMed ID: 2780743
    [No Abstract] [Full Text] [Related]

  • 7. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
    Aoki Y, Ohishi R, Takei R, Matsuzaki O, Mohri M, Saitoh K, Gomi K, Sugihara T, Kiyota T, Yamamoto S.
    Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
    [Abstract] [Full Text] [Related]

  • 8. [Disseminated intravascular coagulation induced by endotoxin in rabbits: effect of treatment with t-PA and urokinase].
    Paloma MJ, Páramo JA, Rifón J, Rocha E.
    Sangre (Barc); 1992 Dec; 37(6):435-8. PubMed ID: 1293794
    [Abstract] [Full Text] [Related]

  • 9. Studies on production of antithrombin III with special reference to endotoxin-induced DIC in dogs.
    Tanaka H, Kobayashi N, Maekawa T.
    Thromb Haemost; 1986 Oct 21; 56(2):137-43. PubMed ID: 3810553
    [Abstract] [Full Text] [Related]

  • 10. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.
    Hanada T, Abe T, Takita H.
    Am J Pediatr Hematol Oncol; 1985 Oct 21; 7(1):3-8. PubMed ID: 4037242
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influence of hirudin on the consumption of antithrombin III in experimental DIC.
    Hauptmann J, Brüggener E.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Oct 21; 115(1-2):83-7. PubMed ID: 2459037
    [Abstract] [Full Text] [Related]

  • 13. Prednisolone inhibits endotoxin-induced disseminated intravascular coagulation and improves mortality in rats: importance of inflammatory cytokine suppression.
    Yamazaki M, Aoshima K, Mizutani T, Ontachi Y, Saito M, Morishita E, Asakura H, Matsuda T, Triplett DA.
    Blood Coagul Fibrinolysis; 1999 Sep 21; 10(6):321-30. PubMed ID: 10493213
    [Abstract] [Full Text] [Related]

  • 14. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
    Rodríguez Gómez M, López Fernández MF, Batlle J.
    Sangre (Barc); 1993 Dec 21; 38(6):449-53. PubMed ID: 8171380
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Current views on the therapeutic use of heparin and antithrombin III in disseminated intravascular coagulation].
    Sobczyk J, Swietliński J, Podleśny-Owsińska T.
    Pol Tyg Lek; 1993 Dec 21; 44(40-42):896-8. PubMed ID: 2487947
    [No Abstract] [Full Text] [Related]

  • 18. Effect of heparin and/or antithrombin III on the generation of endotoxin-induced plasminogen activator inhibitor.
    Gómez C, Páramo JA, Colucci M, Rocha E.
    Thromb Haemost; 1989 Sep 29; 62(2):694-8. PubMed ID: 2683190
    [Abstract] [Full Text] [Related]

  • 19. Protection against disseminated intravascular coagulation and death by antithrombin-III in the Escherichia coli endotoxemic rat.
    Emerson TE, Fournel MA, Leach WJ, Redens TB.
    Circ Shock; 1987 Sep 29; 21(1):1-13. PubMed ID: 3545529
    [Abstract] [Full Text] [Related]

  • 20. Effects of human antithrombin III on mortality and blood coagulation induced in rabbits by endotoxin.
    Triantaphyllopoulos DC.
    Thromb Haemost; 1984 Apr 30; 51(2):232-5. PubMed ID: 6377565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.